Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Paclitaxel + Ipatasertib in PTEN/AKT-Altered Advanced Non-Breast Solid Tumors (ComboMATCH)
NCT05554380Phase 2Active, not recruiting
- Sponsor
- National Cancer Institute
- Start
- Sep 2023
- Primary completion
- Feb 2027
- Countries
- 2
01
Overview
A Phase 2 trial of ipatasertib in solid tumor, sponsored by National Cancer Institute. Started Sep 2023; status: active, not recruiting.
02
Drugs
ipatasertib
03
Conditions
solid tumor
Beyond the preview
Go deeper on NCT05554380.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05554380.